Essex Bio-Technology's total assets for Q2 2024 were HK$2.97B, an increase of 4.89% from the previous quarter. HK:1061 total liabilities were HK$950.33M for the fiscal quarter, a 5.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.